Letter by Koh Regarding Article, 'Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)'

Koh Kwang Kon

首页> 外文期刊>Circulation: An Official Journal of the American Heart Association >Letter by Koh Regarding Article, 'Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)'

【24h】

Letter by Koh Regarding Article, 'Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)'

机译：KOH关于文章的信，“将ezetimibe添加到他汀类药物治疗的有益于没有糖尿病的患者的心血管结果和安全性：改善 - 它的结果（改善了结果减少：Vytorin疗效国际试验）”

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Circulation: An Official Journal of the American Heart Association》 |2018年第17期|共2页
作者
Koh Kwang Kon;
展开▼
作者单位

Gachon Univ Dept Cardiovasc Med Heart Ctr Incheon South Korea;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心脏、血管（循环系）疾病;
关键词

相似文献

外文文献
中文文献

1. Letter by Koh Regarding Article, "Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)" [J] . Koh Kwang Kon Circulation: An Official Journal of the American Heart Association . 2018,第17期

机译：KOH关于文章的信，“将ezetimibe添加到他汀类药物治疗的有益于没有糖尿病的患者的心血管结果和安全性：改善 - 它的结果（改善了结果减少：Vytorin疗效国际试验）”
2. Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial) [J] . Giugliano Robert P., Cannon Christopher P., Blazing Michael A., Circulation: An Official Journal of the American Heart Association . 2018,第15期

机译：在没有糖尿病患者的情况下添加ezetimibe对他汀类药物治疗的益处和患者的患者，没有糖尿病患者改善 - 它的结果（改善了结果：Vytorin疗效国际试验）
3. Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial) [J] . Giugliano Robert P., Cannon Christopher P., Blazing Michael A., Circulation: An Official Journal of the American Heart Association . 2018,第15期

机译：在没有糖尿病患者的情况下添加ezetimibe对他汀类药物治疗的益处和患者的患者，没有糖尿病患者改善 - 它的结果（改善了结果：Vytorin疗效国际试验）
4. Efficacy and Safety of Adding Ezetimibe to Statin Therapy Among Women and Men: Insight From IMPROVE‐IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial) [O] . Eri Toda Kato, Christopher P. Cannon, Michael A. Blazing, -1

机译：在男性和女性的他汀类药物治疗中添加依泽替米贝的疗效和安全性：IMPROVE-IT的见解（改善的结果减少率：Vytorin疗效国际试验）
5. Letter by Koh Regarding Article, “Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)” [O] . Kwang Kon Koh 2018

机译：KOH关于文章的信，“预防卒中与欧洲蛋白综合征患者的急性冠状动脉综合征提高（改善结果的改善：Vytorin疗效国际试验）”

Letter by Koh Regarding Article, 'Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)'

著录项

相似文献

相关主题

期刊订阅